Weight Loss Injections During Ramadan : Can You Use Mounjaro or Wegovy While Fasting?

During Ramadan, many patients ask whether they can safely continue their GLP-1 weight loss injections, including Mounjaro (tirzepatide) and Wegovy (semaglutide), while fasting from dawn until sunset.

If you are observing Ramadan and using or considering starting — a GLP-1 medication for weight management, this guide explains:

• Whether injections break your fast
• The safety considerations during fasting
• Potential side effects to watch for
• When to seek medical advice
• How Pharmulous supports safe prescribing during Ramadan

Do Mounjaro or Wegovy Injections Break Your Fast?

GLP-1 medications are non-nutritive, once weekly subcutaneous injections. They do not provide calories, hydration, or energy.

From a medical perspective, they are not food or drink. Many Islamic scholars consider non-nutritional injections permissible during fasting. However, interpretations may vary, and we always encourage patients to seek personal religious guidance if unsure.

Is It Safe to Fast While Using GLP-1 Medication?

For many patients using Mounjaro or Wegovy for weight loss, fasting during Ramadan can be done safely , provided treatment is stable and well tolerated.

However, GLP-1 medications:

• Reduce appetite
• Slow gastric emptying
• Can cause nausea
• May slightly increase heart rate
• May lower blood pressure in some individuals

Because Ramadan limits eating and drinking to Suhoor and Iftar, careful planning is important to avoid dehydration and side effects.

At Pharmulous, patient safety is always our priority. We assess each case individually before prescribing.

Key Risks to Consider During Ramadan

1. Dehydration

The most important consideration during fasting is fluid intake.

GLP-1 medications can reduce thirst and appetite. If you struggle to drink enough fluids between sunset and dawn, you may experience:

• Headaches
• Dizziness
• Low blood pressure
• Increased heart rate
• Fatigue

Patients prone to lightheadedness or dizziness related to posture should take particular care.

2. Worsening Nausea

If you are early in treatment or increasing your dose, nausea may be more noticeable. Large or high-fat Iftar meals can worsen symptoms.
If nausea limits your ability to eat or drink adequately, continuing treatment during Ramadan may not be advisable without clinical review.

3. Blood Sugar Considerations (Diabetes Patients)

If you are using Mounjaro or semaglutide for type 2 diabetes, particularly alongside insulin or sulfonylureas, medication adjustments may be required before fasting. Please speak to your GP/Diabetic Nurse before you start fasting to ensure you are receiving the best medical advice possible.
If you are using GLP-1 medication solely for weight loss and are not on other glucose lowering treatments, significant hypoglycaemia (low blood sugar) is uncommon but do speak to or contact one of our team members if you have any concerns.

Should You Change Your Injection Day During Ramadan?

Because GLP-1 medications are taken once weekly, most patients do not need to change their dosing schedule.
Some prefer to:

• Take their injection after Iftar
• Avoid starting or increasing doses during Ramadan

At Pharmulous, we often advise avoiding dose escalation during Ramadan unless you are confident in your tolerance and ability to keep well hydrated during your non fasting times.

Practical Tips for Using Mounjaro or Wegovy During Ramadan

If your treatment is stable and you plan to fast:

• Prioritise steady hydration between Iftar and Suhoor
• Avoid very high fat meals at Iftar
• Include balanced protein to maintain satiety
• Monitor for dizziness or persistent nausea
• Delay dose increases until after Ramadan if possible

If you experience significant weakness, dehydration, or concerning symptoms, you should break your fast and seek medical advice.

Should You Start GLP-1 Treatment During Ramadan?

If you are considering starting Mounjaro or Wegovy privately during Ramadan, timing matters.
We may advise:

• Starting treatment before Ramadan so initial side effects settle
• Or waiting until after Ramadan if fasting is a priority

Beginning treatment during a fasting period can make early side effects harder to manage.

Our prescribing clinicians review medical history carefully to ensure safe initiation.

When Should You Speak to a Prescriber Before Fasting?

You should seek personalised advice if you:

• Are within the first 8 weeks of treatment
• Are due to increase your dose
• Experience frequent nausea or vomiting
• Have low blood pressure
• Have a history of fainting or tachycardia (increased heart rate).
• Have diabetes requiring additional medication
• Have other cardiovascular or gastrointestinal conditions that you are concerned about.

At Pharmulous, we do not take a one-size-fits-all approach. Safe prescribing requires understanding your full medical history.

Safe, Responsible Weight Loss During Ramadan

Ramadan is a time of reflection and discipline but health remains a priority. Islamic guidance provides exemptions where fasting may cause harm, and medical safety should never be compromised.

If you are unsure whether you can safely continue Mounjaro or Wegovy during Ramadan, our clinical team can review your history and provide tailored advice.

We are committed to:

• Evidence-based prescribing
• Careful eligibility assessment
• Ongoing safety monitoring
• Transparent communication

If you would like a clinical review before Ramadan, you can begin your consultation online, and our prescribing team will assess whether treatment is appropriate for you.